• Employment Ops.
• People at CIRA
• Affiliated Projects
• Funding Ops (Excel)
• Recorded Talks

CIRA 2023 Fast-Track Funding Supplements in HIV Research

CIRA is accepting submissions for the 2023 Fast-Track Funding Supplements in HIV Research, which offers funding to test innovative extensions of ideas and/or methods as a supplement to an investigator's ongoing IRB-approved study at Yale. The Application Deadline is 5:00 pm on Monday, October 2, 2023. CIRA expects to announce up to three awardees by Tuesday, October 31, 2023.

Download 2023 Funding Announcement and Application Requirements

Save the Date: CIRA's AIDS Science Day - November 30, 2023

In commemoration of World AIDS Day and CIRA's 25th anniversary as a National Institute of Mental Health-funded AIDS Research Center, CIRA is pleased to announce the return of AIDS Science Day that will be held on Thursday, November 30 at the Omni New Haven Hotel at Yale. Researchers, community and practice partners, training fellows, and members of the HIV community, we look forward to seeing you at this special gathering to celebrate the past, present, and future of CIRA research and partnerships.

Registration is forthcoming.

$4 Million Grant Will Help YSPH Team Implement New LGBTQ+ Mental Health Therapy

Yale School of Public Health Professor John Pachankis has received a nearly $4 million grant from the National Institute of Mental Health (NIMH) to implement LGBTQ-affirmative cognitive behavioral therapy in 90 LGBTQ+ community centers nationwide. The grant, totaling $3,973,191 over five years, will help the Yale LGBTQ Mental Health Initiative, which Pachankis directs, determine which of three different strategies is best to implement the novel therapy that he and his research team developed over the past 10 years.

More from Yale School of Public Health

Opara Receives $3.5 Million Grant To Curb Urban Drug Use, Involve Youth in Research

Yale School of Public Health Associate Professor Ijeoma Opara has received the NIDA (National Institute on Drug Abuse) Racial Equity Visionary Award. The award is a NIDA DP1 grant for $3.5 million over five years that will allow her to work within predominantly urban neighborhoods to curb substance use among racial/ethnic minorities.

More from Yale School of Public Health

Lenacapavir: Drug Offers New Hope for Multi-drug Resistant HIV

The U.S. Food and Drug Administration recently approved the medication lenacapavir - a novel antiretroviral drug that can suppress HIV for up to 26 weeks with a single dose - thanks to data in Dr. Onyema Ogbuagu's study which has now been published in The Lancet HIV.

More from Yale School of Medicine

From Research to Impact in the Humanitarian Sector: Learning from R2HC Case Studies
Date: Wednesday, September 13, 2023, 9:00 am-10:30 am
Further Details

NIH Sexual and Gender Minority Research Investigator Awards Program
Date: Wednesday, September 13, 2023, 1:00 pm-3:30 pm
Further Details

R3EDI Webinar: Hybrid Experimental Designs for Optimizing Behavioral Interventions
Date: Wednesday, September 13, 2023, 2:00 pm-3:00 pm
Contact Alane Kelly (alane.kelly@yale.edu) for Zoom invitation.

Designing Semi-structured Interviews for Rapid Turnaround Qualitative Work
Date: Thursday, September 14, 2023, 12:00 pm-1:00 pm
Further Details

The Theoretical and Practical Importance of Advancing Health Equity
Date: Tuesday, September 19, 2023, 2:00 pm-3:00 pm
Further Details

NIDA 2023 HIV Avenir Symposium
Date: Wednesday, September 20, 2023, 1:00 pm-4:00 pm
Further Details

Implementation Science Methods Workshop: Implementation Cost Analysis
Date: Friday, September 22, 2023, 12:00 pm-1:30 pm
Further Details

Community-based System Dynamics Workshop Series
Date: September 27, October 25, November 22, 2023
Further Details

Yale Conference for Alcohol Research and Education
Date: Saturday, September 30, 2023
Further Details

Mentoring the Mentors Workshop for HIV Researchers
Registration Due Date: September 14, 2023
Date: October 24-25, 2023
Further Details

NIMH Global Mental Health Conference (Hybrid)
Date: October 30-November 1, 2023
Further Details

Call for Abstracts: 2023 Inter-CFAR Women and HIV Symposium
Submission Due Date: September 18, 2023
Further Details

Call for Applications: The Greenwall Foundation Faculty Scholars Program
Letter of Intent Due Date: September 18, 2023
Application Due Date (By Invitation): January 8, 2024
Further Details

Call for Applications: Fulbright-Fogarty Fellowships in Public Health
Eligibility: US advanced medical and PhD students
Application Due Date: October 10, 2023
Further Details

Call for Applications: Mathilde Krim Fellowships in Biomedical Research 2023
Letter of Intent Due Date: October 10, 2023
Full Applications Due Date (By Invitation): mid-December 2023
Further Details

Call for Proposals: Case Studies to Advance Research on Climate Change
Adaptation Strategies and Their Impact on Public Health
Application Due Date: October 16, 2023
Further Details

Call for Applications: Center for Health Equity Research (CHER) Institute 2023
Applications Due Date: October 18, 2023
Further Details

Call for Papers: JSAT "Addiction Treatment Implementation Research"
Submission Due Date: November 1, 2023
Further Details

Call for Papers: APA "Psychology in the Digital Age"
Submission Due Date: November 15, 2023
Further Details

Call for Papers: JCTS "Advancing Understanding and Use of Impact Measures in Implementation Science"
Submission Due Date: February 15, 2024
Further Details

Call for Papers: BMC Health Services Research "Disasters, Crisis, and Emergency Management within Health Services"
Submission Due Date: February 28, 2024
Further Details

Download an Excel spreadsheet compilation of active funding opportunities. Opportunities previously not listed are below.

Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01)
Application Due Date: December 1, 2023
Further Details

Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01)
Application Due Date: December 1, 2023
Further Details

Women's Health Research at Yale's Pilot Project Program Funding
Eligibility: Yale faculty members (investigators outside the Yale community are invited to collaborate with Yale or Yale-affiliated principal investigators)
Letter of Intent Due Date: October 19, 2023
Full Applications Due Date (By Invitation): January 5, 2024
Further Details

PCORI Engagement Awards
Letter of Intent Due Date: September 28, 2023
Application Due Date (By Invitation): January 10, 2024
- Capacity Building
- Dissemination Initiative
- Stakeholder Convening Support

Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women
AIDS Application Due Date(s): November 22, 2023
- R01 Clinical Trial Optional
- R21 Clinical Trial Optional
- R34 Clinical Trial Optional

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC³H-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
AIDS Application Due Date(s): December 6, 2023
Further Details

Addressing HIV in Highest Risk Sexual and Gender Minorities
Application Due Date: July 14, 2024
- R01
- R34

Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Application Due Date: August 5, 2024
Further Details

Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services
Application Due Dates: August 20, 2024; March 19, 2025
- R01
- R34

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
AIDS Application Due Dates: Standard AIDS Dates Apply (Expiration Date: September 8, 2025)
Further Details

NOSI: Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Expiration Date: September 08, 2026
Further Details

NOSI: Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 Clinical Trial Optional)
Expiration Date: September 08, 2026
Further Details

NOSI: Role of social function on SUD treatment and outcomes
Expiration Date: September 08, 2026
Further Details

NOSI: Innovative technologies to develop novel tools to prevent and treat HIV in underserved populations
Expiration Date: January 6, 2027
Further Details

Sexual Health and Drug Use Prevention for Black Girls (The Dreamer Girls Project): Protocol for an Intervention Development
Ijeoma Opara, Cora Gabriel, Beatriz Duran-Becerra, Keosha Bond, Ashley V Hill, Sydney Hussett-Richardson, Courtnae Alves, Trace Kershaw
JMIR Research Protocols. 2023. Aug 9;12:e45007. doi: 10.2196/45007.

Global HIV control: is the glass half empty or half full?
Jean B Nachega, Philippa Musoke, Peter H Kilmarx, Monica Gandhi, Beatriz Grinsztejn, Anton Pozniak, Angeli Rawat, Lindsay Wilson, Edward J Mills, Frederick L Altice, John W Mellors, Thomas C Quinn
Lancet HIV. 2023. Sep;10(9):e617-e622. doi: 10.1016/S2352-3018(23)00150-9. Epub 2023 Jul 25.

Perspectives on contingency management for alcohol use and alcohol-associated conditions among people in care with HIV
Shawn M Cohen, Dominick DePhilippis, Yanhong Deng, James Dziura, Tekeda Ferguson, Lisa M Fucito, Amy C Justice, Stephen Maisto, Vincent C Marconi, Patricia Molina, Manuel Paris, Maria C Rodriguez-Barradas, Michael Simberkoff, Nancy M Petry, David A Fiellin, E Jennifer Edelman
Alcohol, Clinical & Experimental Research. 2023. Jul 31. doi: 10.1111/acer.15159. Online ahead of print.

Associate Research Scientist
Organization: Yale School of Public Health
Further Details

SD CFAR Qualitative Methods for Implementation Research and Community Engagement Series
Further Details

AIDSVu 2021 Data and Interactive Maps Visualizing HIV Data Across the US
Further Details

Summary Report: Community Engagement in Health Research in the Context of Humanitarian Crises
Further Details

Summary Report: Request for Information on Promoting Equity in Global Health Research
Further Details

Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection—Medical Monitoring Project, United States 2021 Cycle (June 2021–May 2022)
Further Details

NOTE: All times are expressed in Eastern Time unless otherwise noted. All dates refer to 2023 unless otherwise noted.

Spotlight on CIRA

CANCELLED: CIRA's Qualitative Research Discussion Group (QRDG)

The QRDG meeting scheduled for Friday, September 15 has been cancelled. The next meeting will take place on Friday, October 20, 12:00 pm-1:00 pm.

Fact Sheets and Resources on Mpox

This webpage provides fact sheets, resources, recorded sessions and literature on Mpox collated by CIRA.

More from CIRA

COVID-19 and HIV Resources

This webpage provides a wide range of resources surrounding COVID-19 and HIV collated by CIRA, including funding opportunities, call for papers, and repositories of literature and research tools.

CIRA Peer Review Program

CIRA's Peer Review Program is designed to enhance the quality of grant proposals, manuscripts, and research presentations written by CIRA affiliates by sharing them with a multidisciplinary group of colleagues for their critique and feedback. The spirit of our program is one of collegiality and respect; it is constructive rather than evaluative in nature. We encourage peer review at any stage of development, from a 2-3 page concept sheet to a penultimate draft.

Please submit your request for Peer Review 4 weeks prior to requested review date. Review materials are due:

• Specific Aims: 5 days in advance of the review date
• Grant Sections (i.e. approach, significance etc): 7 days in advance of the review date
• Full Grant proposal: 14 days in advance of the review date
• Sections of a paper (i.e. methods, tables, discussion etc): 7 days in advance of the review date
• Full Manuscript: 10 days in advance of the review date
• Concept paper: 5 days in advance of the review date
• Conference Presentation: nothing due in advance
• Conference Poster: 5 days in advance of the review date

Sessions are held at CIRA's Offices (135 College Street, Suite 200, New Haven CT) on Zoom, or via email and last around one hour. Reviews are typically led by a primary reviewer; whose role is to provide oral and written feedback on each proposal. This is followed by the other reviewers’ feedback and then we hold a group discussion.

The peer review process has multiple benefits: Researchers gain from practical advice on products. Also, they offer a rare opportunity for a cross-section of the entire CIRA community – scientists, staff, community representatives and post-doctoral fellows – to keep abreast of and discuss the very latest research, to forge additional, cross-disciplinary collaborations, and to expand and build on professional networks.

To request a Peer Review, please click here. For further information or questions, please contact Daniel Davidson (daniel.davidson@yale.edu).

Research Snapshot Series

CIRA's Research Snapshot series features one page summaries of completed, peer reviewed and published studies conducted by our affiliated scientists. The summaries describe the reason for the study, the key findings, and implications for practice and policy, presented in plain language. Each of the briefs also include a link to a published article in a peer reviewed journal that derives from the featured study.

If you are a CIRA Affiliate and interested in submitting a brief for publication or just want to discuss the process, contact Pete Donohue, pete.donohue@yale.edu.

Meeting Challenges & Taking Action: Highlights of CIRA Activities and Accomplishments

Collaborators past, present and future, we invite you to peruse this concise summary of "CIRA Highlights" from the past year, and welcome any comments/suggestions you may have for future representation of your engagement with CIRA.

Download PDF

Did you know our eBulletin is Archived?

For your convenience, we have archived all issues of CIRA's eBulletin. No need to dig through your emails to find an old issue.
View the Archive